Clinical

HCV linked to Parkinson’s disease?

Infection with hepatitis C may increase the risk of developing Parkinson’s disease

Saturday reflections: Missing piece in the diabetes jigsaw?

Could technology prove to be the missing piece in the great diabetes malady jigsaw?

BP targets should be lower

Clinical evidence now offers “strong support” to reduce systolic blood pressure to less than 130mmHg

Pharmacists help to cut opioid-related deaths

Data suggests pharmacists in Scotland’s National Naloxone Programme are reducing opioid-related deaths

Adherence to statins cuts stroke risk

Poor adherence to statins may increase ischaemic stroke risk, according to a new study

Inequalities persist in dementia prescribing

A new study reveals that inequalities in anti-dementia drug (ADD) prescribing persist in England

Dulaglutide gets green light in Scotland

The Scottish Medicines Consortium has accepted Trulicity (dulaglutide) for use in NHS Scotland.  

New COPD inhalers

Two new inhaler devices have been launched for the treatment of COPD

Chondroitin comes out on top

Chondroitin sulphate reduces long-term progression of knee osteoarthritis more effectively than celecoxib?

Previous 1 ... 7 8 9 10 11 Next

Latest

Sigma day 1: contract negotiations to begin shortly

Negotiations on the new community pharmacy contractual framework are due to begin shortly, Brine tells conference

MHRA recalls heart and blood pressure medication

The MHRA has recalled three batches of blood pressure and heart medication Irbesartan due to contamination fears

Views

Where next for the NHS Long-Term Plan?

By Royal Pharmaceutical Society England board chair Sandra Gidley As the dust settles from the publication of the long-...

Popular

Boots seeks to crack digital healthcare with acquisition

Boots has acquired a digital health company in a move that will link customers to their GP records

Most expensive NHS drug comes off patent

Adalimumab (Humira; AbbVie) is a biological medicine used to treat conditions including rheumatoid arthritis and Crohn&r...

Aspirin may cut ovarian cancer risk

Aspirin may reduce the risk of developing ovarian cancer, reports JAMA Oncology



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.